يعرض 1 - 20 نتائج من 98 نتيجة بحث عن '"Ivelina Gueorguieva"', وقت الاستعلام: 0.59s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    المصدر: Journal of Clinical Oncology. 39:1108-1118

    وصف الملف: Print-Electronic

  15. 15
    Academic Journal
  16. 16
  17. 17
  18. 18

    المصدر: Cancer medicine, vol 10, iss 9
    Cancer Medicine, Vol 10, Iss 9, Pp 3059-3067 (2021)
    Cancer Medicine

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Vascular Endothelial Growth Factor A, Male, Cancer Research, Receptor, Transforming Growth Factor-beta Type I, chemistry.chemical_compound, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Monoclonal, 80 and over, Medicine, Prospective Studies, HCC, Humanized, RC254-282, Original Research, Cancer, Aged, 80 and over, Liver Disease, Liver Neoplasms, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Nausea, hepatocellular carcinoma, Middle Aged, VEGF, Vascular endothelial growth factor, Transforming Growth Factor-beta Type I, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, 6.1 Pharmaceuticals, Quinolines, Female, alpha-Fetoproteins, medicine.symptom, Receptor, TGF-β, medicine.medical_specialty, Carcinoma, Hepatocellular, Combination therapy, Maximum Tolerated Dose, Vomiting, ramucirumab, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Antineoplastic Agents, Phase 1, Antibodies, Monoclonal, Humanized, Antibodies, Ramucirumab, 03 medical and health sciences, Rare Diseases, Pharmacokinetics, Clinical Research, Internal medicine, Galunisertib, Humans, Radiology, Nuclear Medicine and imaging, Adverse effect, Response Evaluation Criteria in Solid Tumors, TGF‐β, Aged, business.industry, Carcinoma, Clinical Cancer Research, Hepatocellular, medicine.disease, Vascular Endothelial Growth Factor Receptor-2, 030104 developmental biology, chemistry, galunisertib, Pyrazoles, Biochemistry and Cell Biology, business, Digestive Diseases

    وصف الملف: application/pdf

  19. 19

    المساهمون: Institut Català de la Salut, [Melisi D] Digestive Molecular Clinical Oncology Research Unit, Section of Medical Oncology, Università degli Studi di Verona, Verona, Italy. [Oh DY] Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. [Hollebecque A] Institut Gustave Roussy, Villejuif, France. [Calvo E] START Madrid–CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain. [Varghese A] Memorial Sloan Kettering Cancer Center, New York, New York, USA. [Borazanci E] HonorHealth Research Institute, Scottsdale, Arizona, USA. TGen, Phoenix, Arizona, USA. [Macarulla T] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia
    Journal for Immunotherapy of Cancer
    Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Durvalumab, Time Factors, medicine.medical_treatment, Receptor, Transforming Growth Factor-beta Type I, B7-H1 Antigen, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Other subheadings::/therapeutic use [Other subheadings], Neoplasm Metastasis, Immune Checkpoint Inhibitors, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias pancreáticas [ENFERMEDADES], RC254-282, Clinical/Translational Cancer Immunotherapy, Aged, 80 and over, biology, clinical trials as topic, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Antibodies, Monoclonal, Middle Aged, Progression-Free Survival, Europe, 030220 oncology & carcinogenesis, Disease Progression, Quinolines, Molecular Medicine, Female, immunotherapy, Antibody, Signal Transduction, Adult, medicine.medical_specialty, Combination therapy, Immunology, therapies, investigational, 03 medical and health sciences, Refractory, Pharmacokinetics, Internal medicine, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Republic of Korea, Pàncrees - Càncer - Tractament, medicine, Galunisertib, tumor microenvironment, Humans, Protein Kinase Inhibitors, Aged, Pharmacology, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms [DISEASES], business.industry, Otros calificadores::/uso terapéutico [Otros calificadores], diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Immunotherapy, medicine.disease, Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], United States, Pancreatic Neoplasms, 030104 developmental biology, tumor biomarkers, biology.protein, Avaluació de resultats (Assistència sanitària), Pyrazoles, business, Progressive disease

    وصف الملف: application/pdf

  20. 20

    المساهمون: Institut Català de la Salut, [Wick A] Clinical Cooperation Unit Neuro-oncology, German Cancer Research Center, Heidelberg University Medical Center, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. [Desjardins A] The Preston Robert Tisch Brain Tumor Center at Duke, Duke University, Durham, NC, USA. [Suarez C] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Forsyth P] H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. [Gueorguieva I] Eli Lilly and Company, Erl Wood, UK 6 Eli Lilly and Company, Indianapolis, IN, USA. [Burkholder T] Eli Lilly and Company, Indianapolis, IN, USA. [Rodon J] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, U. T. M. D. Anderson Cancer Center, Houston, TX, USA, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Recercat: Dipósit de la Recerca de Catalunya
    Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
    Scientia
    Investigational New Drugs
    Dipòsit Digital de Documents de la UAB
    Universitat Autònoma de Barcelona
    Recercat. Dipósit de la Recerca de Catalunya
    instname

    وصف الملف: application/pdf